Dr. Welling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles St
Boston, MA 02114Phone+1 617-523-7900
Summary
- D. Bradley Welling, MD, PhD is a distinguished otolaryngologist located in Boston, MA, specializing in neurotology. His academic journey includes a medical degree from the University of Utah, surgical internship and residency in Otolaryngology at the University of Iowa Hospitals and Clinics, and a Ph.D. in Pathobiology from The Ohio State University. He chaired the Otolaryngology Head and Neck Surgery Departments at The Ohio State University and Harvard University. He has considerable experience dealing with conditions such as NF2-related schwannomatosis and vestibular schwannomas. Dr. Welling currently holds the position of Walter Augustus Lecompte Distinguished Professor at Harvard Medical School and has published over 180 peer-reviewed articles and 35 chapters. He is also actively involved in funded clinical trials as a principal investigator.
Education & Training
- The Ohio State UniversityPh.D., Pathobiology, 1996 - 2003
- University of Iowa Hospitals and ClinicsResidency, Otolaryngology - Head and Neck Surgery, 1984 - 1988
- University of Iowa Hospitals and ClinicsInternship, Surgery, 1983 - 1984
- University of Utah School of MedicineClass of 1983
Certifications & Licensure
- MA State Medical License 2014 - 2026
- MA State Medical License 2013 - 2024
- OH State Medical License 1989 - 2015
- IA State Medical License 1983 - 1990
- TN State Medical License 1988 - 1989
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
- American Board of Otolaryngology - Head and Neck Surgery Neurotology
Clinical Trials
- Study of Aspirin in Patients With Vestibular Schwannoma Start of enrollment: 2018 Jun 11
Roles: Principal Investigator, Contact
- Doxycycline in Cutaneous Schwannoma (NF2) Start of enrollment: 2022 Sep 19
Roles: Principal Investigator, Contact
- In-office Repair of Chronic Tympanic Membrane Perforations Start of enrollment: 2024 Jun 15
Roles: Sponsor-Investigator, Principal Investigator, Contact
Publications & Presentations
PubMed
- 11 citationsAmerican Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Foundation Guide to Enhance Otologic and Neurotologic...Elliott D. Kozin, Aaron K. Remenschneider, Nikolas H. Blevins, Taha A. Jan, Alicia M. Quesnel
Otology & Neurotology. 2020-08-20 - 45 citationsThree-Dimensional Segmented Volumetric Analysis of Sporadic Vestibular Schwannomas Comparison of Segmented and Linear MeasurementsPatrick C. Walz, Matthew L. Bush, Zachary N. Robinett, Claudia Kirsch, D. Bradley Welling
Otolaryngology--Head and Neck Surgery. 2012-05-15 - 85 citationsConsensus Recommendations for Current Treatments and Accelerating Clinical Trials for Patients with Neurofibromatosis Type 2Jaishri O. Blakeley, D. Gareth Evans, John R. Adler, Derald E. Brackmann, Ruihong Chen
American Journal of Medical Genetics. Part A. 2012-01-01
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: